Monoclonal antibodies (mAbs) to selected muscle proteins were assessed as potential immunohistochemical markers to assist in the definitive diagnosis of poorly differentiated soft tissue sarcomas in rats. A series of 7 rat rhabdomyosarcomas (RMS) induced with nickel subsulfide were studied by light microscopy and were evaluated for immunoreactivity to desmin, vimentin, fast (type II isoform) skeletal myosin, &alpha;-actin (smooth muscle isoform), or MyoD 1 (myogenic regulatory protein) mAbs using an avidin-biotin-chromogen technique. Consecutive RMS slices were fixed in 10% neutral buffered formalin (the fixative routinely used in carcinogenicity bioassays) for periods of 3 days or 2 mo prior to paraffin embedding to determine the effect of fixation time on immunoreactivity. Desmin and vimentin mAbs bound to many cells of all tumors, but fixation for 2 mo resulted in irretrievable loss of desmin and vimentin binding. Fast myosin and &alpha;-actin mAbs bound to many cells in 1 RMS but to <1% of the cells in the remainder. MyoD1 mAb bound to tumor cell nuclei in 5/7 RMS with no loss of staining in tissue fixed for 2 mo. Results indicate that MyoD1 immunostaining, in contrast to desmin, maintains its sensitivity following prolonged formalin fixation and may be of value to distinguish RMS from other soft tissue sarcomas in the rat.
INTRODUCTION
Poorly differentiated soft tissue sarcomas occurring in rats in carcinogenicity studies can be diagnostically challenging. Such tumors, when examined using conventional histological methods, express minimal features to indicate their origin, and consequently many of them defy precise classification. Similar diagnostic difficulties encountered in human pathology have led to the application of immunohistochemical procedures for more reliable classification of poorly differentiated sarcomas and, importantly, to help distinguish rhabdomyosarcomas (RMS) from other tumor types. Antibodies raised to certain muscle proteins have proved to be specific and reliable markers in this regard. These include desmin (1, 13) , myosin (6) and, more recently, myogenic regulatory protein (MyoDl) (8, 17, 25) .
Antibodies to desmin (1, 18, 22) and myoglobin (22) have also been reported, among others, as effective immunohistochemical markers for RMS in rats, but the reliability of such markers has not been objectively evaluated using tissue fixation conditions generally employed in cancer bioassays. In such studies, formalin remains the most widely used fixative even though it is not ideal for immunostaining and preferred alternatives have been suggested (4) . The large scale of typical cancer bioassays also imposes logistical constraints which necessitate that tissues cannot always be processed immediately but rather undergo prolonged immersion in formalin. It is important to evaluate antibodies under such conditions because the immunoreactivity of paraffin-embedded tissues to a number of antibodies routinely used in tissue diagnosis is known to decrease progressively with fixation time in formalin (4, 12) .
The objective of this study was to evaluate potential immunohistochemical markers under conditions applicable to rat cancer bioassays. The immunoreactivity of nickel subsulfide-induced rat RMS to commercially obtained monoclonal antibodies (mAbs) to selected muscle proteins was assessed after short-term and prolonged formalin fixation (15) .
METHODS

Production of Muscle Tumors with Nickel Subsulfide (Ni3S2)
Ten male Sprague-Dawley (Crl:CDOBR) rats, 10-wk old, obtained from Charles River Laboratories (Raleigh, NC) were used. Tumors were induced by single im injection of nickel subsulfide (Ni3S2) after the method originated by Gilman (9) . Ni3S2 powder (Inco Ltd., Toronto, Canada) was prepared as a suspension in 50% aqueous glycerol and 5 mg/site was injected into muscle of each thigh. Rats were individually caged and were fed Certified Purina Rodent Chow ad libitum throughout the study. They were observed daily and examined weekly for the presence of palpable masses. Rats were promptly sacrificed by CO, exposure when a hindlimb mass was observed or in the event of declining clinical condition. Remaining rats were sacrificed 12 mo following injection. The study conformed to National Institutes of Health guidelines for animal use (14) .
Tissue Collection and Fixation
All rats were necropsied. Injection sites, lungs, inguinal lymph nodes, and all visible masses were collected Table I . Antigen retrieval methods, which consisted of digestion with proteinase K (DAKO) for 15 min, steaming in citrate buffer for 20 min, or heating in a microwave oven (20) , were attempted on selected tissue sections for desmin and vimentin staining.
RESULTS
Occurrence and Histology of RMS Results are summarized in Table II . Ni,S2 injection resulted in the occurrence of primary masses (left or right thigh) in 7 of 10 rats (7 masses of 20 sites) between 6 and 9 mo postinjection. All masses were rapidly growing and locally aggressive, with areas of necrosis and hemorrhage. Metastasis to lymph node was evident for all and metastases to lung and heart were also observed. Histologically, tumors were composed of dense sheets of cells with numerous mitoses. Histological pattern was classified based on examination of metastatic sites, where possible, since preexistent myofibers entrapped by the growing tumor were often present at the primary site and made interpretation more difficult. Histological appearance varied somewhat from site to site for each rat, but 4 patterns were recognized based on predominant cytological features: (a) poorly differentiated, consisting of sheets of small, polygonal cells with scant, eosinophilic cytoplasm ( Fig. la) ; (b) fusiform pattern, consisting of sheets of short, spindle-shaped cells (Fig. lb) ; (c) pleomorphic pattern with syncytia interspersed with polygonal cells (Fig. 1 c) ; and (d) pleomorphic pattern with strap-like cells interspersed with fusiform cells (Fig. ld ).
Cross striations were not observed in cells within metastases for any of these patterns.
Immunohistochemistry of Control Tissues
Skeletal muscle, myocardium, and the smooth muscle of intestine, uterus and the media of small arteries stained strongly and selectively with desmin. Smooth muscle of intestine, uterus and blood vessels stained strongly with a-actin; skeletal and cardiac myofibers did not stain.
Smooth muscle of uterus and intestine, the walls of blood vessels and connective tissue stroma, but not skeletal or cardiac myofibers, stained with vimentin. Most skeletal myofibers stained strongly with fast myosin; myocardium and smooth muscle did not stain. No staining was observed with MyoDl.
Immunohistochemistry of RMS
Results are summarized in Table III and illustrated in Fig. 2 . For each rat, no immunohistochemical differences were observed between metastatic sites and the primary mass. Most tumor cells of all types (polyhedral, fusiform, strap cells, and sycytia) displayed strong cytoplasmic staining with desmin in all tumors in tissue fixed for 3 days (Fig. 2c ), but desmin immunoreactivity was lost, in some cases totally, in tissue fixed for 2 mo (Fig. 2d ). A similar pattern of staining, with loss of immunoreactivity in tissue fixed for 2 mo, occurred with vimentin ( Fig. 2e , f). Parallel loss of desmin and vimentin immunoreactivity was also seen in walls of blood vessels within and adjacent to the tumors. Efforts to retrieve desmin or vimentin immunoreactivity with proteinase K digestion, steam, or microwave treatments were uniformly unsuccessful. With smooth muscle a-actin or fast myosin, positive immunostaining was observed for many polygonal cells and syncytia in RMS from rat 6, but staining for these proteins in other RMS was either absent or confined to very few cells « 1 %). With MyoDl, strong nuclear staining was observed in many cells (Fig. 2b ) in 5 of 7 RMS but < 1 % cells in the remainder. MyoDl immunoreactivity persisted in tissues fixed for 2 mo.
DISCUSSION
RMS induced in rats by Ni3S2 injection have been previously grouped according to their predominant cellular constitution into 6 subtypes: well differentiated, poorly differentiated, embryonal, mesenchymal, leiomyosarcoma-like, and fibrosarcoma-like (26) . Of the series of 7 RMS in the present study, 4 with predominantly polygonal or fusiform cells were consistent with the poorly differentiated type, and the 3 that contained strap cells or syncytia were more consistent with the well-differentiated type. Other types were not represented in this series. The poorly differentiated types (sheets of nondescript polygonal cells) were particularly useful for evaluating immunohistochemical markers since features of muscle origin were lacking with conventional H&E staining.
Of the muscle proteins evaluated, desmin is an intermediate filament protein expressed by skeletal, cardiac, and smooth muscle (10) . Desmin was strongly expressed in all the tumors. This is consistent with other reports that desmin is a sensitive and reliable marker of muscle tumors in rats (1, 18, 22) as well as in humans (1, 11) . The desmin antibody (Clone D33, DAKO) gave very consistent results in our hands, which is important to note since all desmin antibodies obtainable commercially do not provide uniform results (11) . Since desmin is expressed in smooth as well as skeletal muscle, it will not differentiate RMS from tumors of smooth muscle origin. An additional shortcoming evident from the present study was that prolonged formalin fixation resulted in substantial and irretrievable loss of desmin immunoreactivity. This is a serious disadvantage when evaluating tissues from bioassay studies since long-term formalin fixation is the routine procedure. Vimentin is an intermediate filament protein, not specific to muscle, expressed in tissues of mesenchymal origin. The epitope for the vimentin mAb we used (DAKOvimentin, clone V9) is known to be susceptible to formalin fixation, but this mAb has found a place in human pathology as a useful monitor or internal control in the interpretation of immunostaining with other diagnostically useful antibodies known to be affected by formalin (3) . The loss of vimentin immunoreactivity following prolonged formalin fixation in this study was in close parallel to that seen with the desmin mAb, which illustrates the value of this vimentin mAb as an internal con- trol when evaluating desmin staining in formalin-fixed rat sarcomas. However, study results also indicate that desmin immunoreactivity of small arteries within or adjacent to the mass offers an effective and more convenient alternative internal control.
An antibody to the smooth muscle isoform of a-actin (clone asm-1 ) (21) has proved useful in the diagnosis of human smooth muscle tumors (19) and we have also observed strong immunoreactivity to it in rat smooth muscle tumors (15) . This mAb, therefore, offers a means for dis-tinguishing smooth from skeletal muscle origin. Results of this study, however, indicate that it is not infallible in this regard since cells stained with a-sm actin in several RMS of this series. Others have described a-sm actin expression in rat RMS and also the coexpression of other a-actin isoforms in the same cells, suggesting that a-sm actin expression may represent a stage in the differentiation of RMS (2) . We did not evaluate other actin antibodies in this study because they did not perform reliably in our hands in preliminary work. However, we acknowl-edge their potential as useful and specific markers of skeletal muscle origin. An a-sarcomeric actin antibody, for example, proved a constitent marker in a series of rat RMS (2); such antibodies clearly deserve further evaluation as formalin-resistant markers.
Antisera raised against fast myosin heavy chain (expressed in fast or type II myofibers) have been reported as a useful tool for diagnosing human RMS in formalin fixed material (6) , and consistent expression of adult fasttype myosin heavy chains has also been described in nickel-induced rat RMS (5) . Consequently, positive staining with the fast myosin mAb in only 1 rat RMS was surprising to us. The reason for this disappointing result is not clear; sarcoplasm of myofibers stained strongly with this mAb in thigh muscles adjacent to RMS and also in the control sections of normal rat tissues, which would indicate that the mAb is sufficiently sensitive.
The MyoD gene is important in controlling commitment of cells towards myogenic differentiation. The gene product is a nuclear phosphoprotein, which is expressed in embryonic muscle but is not detected in normal adult muscle (7, 23) . Increased MyoDl expression has also been observed in regenerative myofibers of patients with myopathies (16) and in response to denervation in rat muscle (24) . However, in normal, fully differentiated rat skeletal muscle, MyoD 1 expression is minimal or absent (24) . MyoD antibodies are sensitive and highly specific markers of skeletal muscle differentiation and are proving of value in human pathology as immunohistochemical tools in the challenging task of differentiating RMS from other soft tissue sarcomas both in children (8) and in adults (17, 25) . We observed strong nuclear staining with MyoDl mAb in 5 of 7 rat RMS, and immunoreactivity was not decreased by prolonged formalin fixation. These results suggest that MyoD 1 may be a useful marker for rat RMS and warrants a fuller evaluation across a broader range of rat tumor types.
Results of this study indicate that desmin immunostaining is not sensitive as a marker of muscle in rat tissues subjected to prolonged formalin fixation. MyoDl 1 immunostaining, on the other hand, maintains its sensitivity following prolonged formalin fixation and offers potential as a means of distinguishing RMS from other soft tissue sarcomas in the rat. ' 
